Anthracycline analogs: the past, present, and future (Q39480685)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Anthracycline analogs: the past, present, and future	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2948729

retrieved

12 September 2017

review article

1 reference

stated in

Europe PubMed Central

title

Anthracycline analogs: the past, present, and future (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2948729

retrieved

12 September 2017

author name string

R B Weiss

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2948729

retrieved

12 September 2017

G Sarosy

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2948729

retrieved

12 September 2017

K Clagett-Carr

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2948729

retrieved

12 September 2017

M Russo

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2948729

retrieved

12 September 2017

B Leyland-Jones

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2948729

retrieved

12 September 2017

language of work or name

English

1 reference

based on heuristic

inferred from title

publication date

1 January 1986

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2948729

retrieved

12 September 2017

published in

Cancer Chemotherapy and Pharmacology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2948729

retrieved

12 September 2017

volume

18

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2948729

retrieved

12 September 2017

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2948729

retrieved

12 September 2017

page(s)

185-197

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2948729

retrieved

12 September 2017

cites work

Phase I study of 4-demethoxydaunorubicin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorescence assays and pharmacokinetic studies of 4′-deoxydoxorubicin and doxorubicin in organs of mice bearing solid tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electrocardiographic and transmembrane potential effects of 5-iminodaunorubicin in the rat

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of 4'-epi-doxorubicin in metastatic colorectal carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity and distribution of iv and oral 4-demethoxydaunorubicin in murine experimental tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adriamycin (NSC-123,127): a new antibiotic with antitumor activity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of 4-demethoxydaunorubicin in advanced ovarian carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between effects on nucleic acid synthesis in cell cultures and cytotoxicity of 4-demethoxy derivatives of daunorubicin and adriamycin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and clinical pharmacological evaluation of 4'-deoxydoxorubicin in patients with advanced cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of 4-demethoxydaunorubicin in patients with non-small cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lung

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Daunorubicin treatment of adult solid tumors.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete remission in prolymphocytic leukemia with 4-demethoxydaunorubicin and arabinosyl cytosine.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of 4'-deoxydoxorubicin given weekly

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary phase I study of 4'-epi-adriamycin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Necropsy study of 4 patients treated with rubidomycin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical phase I trial of marcellomycin with a single-dose schedule

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase of I trial of 4'-epi-Adriamycin.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of 4-demethoxydaunorubicin in advanced colorectal carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new antitumor antibiotic, carminomycin (NSC-180024)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of 4'-epi-doxorubicin in advanced colorectal carcinoma: a Northern California Oncology Group study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epirubicin in non-Hodgkin's lymphomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of oral 4-demethoxydaunorubicin in patients with non-small cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac complications observed during treatment with rubidomycin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study with 4'-deoxydoxorubicin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absence of generation of oxygen-containing free radicals with 4′-deoxydoxorubicin, a non-cardiotoxic anthracycline drug

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RUBIDOMYCIN: A NEW ANTIBIOTIC WITH CYTOSTATIC PROPERTIES

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antileukemic activity of 4-demethoxydaunorubicin in mice

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy of human colorectal tumor xenografts in athymic mice with clinically active drugs: 5-fluorouracil and 1-3-bis-(-2-chloroethyl)-1-nitrosourea (BCNU). Comparison with doxorubicin derivatives: 4'deoxydoxorubicin and 4'-O-methyldoxorubicin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of 4'-epi-doxorubicin in man

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental evaluation of anthracycline analogs

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EXPERIMENTAL STUDIES OF THE ANTINEOPLASTIC ACTIVITY OF A NEW ANTIBIOTIC, DAUNOMYCIN

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity in mice of 4'-deoxydoxorubicin in comparison with doxorubicin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase-II trial of 4-demethoxydaunorubicin (DMDR) for advanced hypernephroma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensely potent morpholinyl anthracyclines

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Idarubicin alone or in combination with cytarabine and etoposide (3 + 3 + 5 protocol) in acute non-lymphoblastic leukaemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of esorubicin (4'deoxydoxorubicin).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical evaluation of adriamycin, a new antitumour antibiotic

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of 4-demethoxydaunorubicin in patients with adenocarcinoma of the upper gastrointestinal tract

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of 4-demethoxydaunorubicin in patients with advanced malignant melanoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic cardiotoxicity studies in rabbits with 7-con-O-methylnogarol, a new anthracycline antitumor agent

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of 4'-epi-doxorubicin in patients with advanced malignant melanoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of the fast-exchanging calcium compartment in the early cardiotoxicity of anthracycline analogs

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative pharmacokinetics and metabolism of doxorubicin and epirubicin in patients with metastatic breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and antitumor activity of 4'-deoxydaunorubicin and 4'-deoxyadriamycin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis, antitumor activity, and cardiac toxicity of new 4-demethoxyanthracyclines

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of 4-demethoxydaunorubicin (idarubicin) with single oral doses

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

4-Demethoxydaunorubicin (Idarubicin) in refractory or relapsed acute leukemias. A pilot study.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of 4'-epi-doxorubicin in metastatic melanoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial clinical evaluation of N-trifluoroacetyladriamycin-14-valerate (AD-32), an adriamycin analog

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical investigation of 7-con-O-methylnogaril, a new anthracycline antibiotic

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of Biochemical and Biological Methods in the Evaluation of New Anthracycline Drugs

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of 4'-deoxydoxorubicin in patients with advanced breast cancer.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of 4-demethoxydaunorubicin by the oral route in advanced breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of 4'-epi-doxorubicin in advanced breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adriamycin--an antitumor antibiotic in the treatment of neoplastic diseases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antitumoral activity of 4'-deoxydoxorubicin compared to doxorubicin and 5-fluorouracil on methylazoxymethanol acetate-induced colon tumors in CF1 mice

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New doxorubicin analogs active against doxorubicin-resistant colon tumor xenografts in the nude mouse

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism of 4'-modified analogs of doxorubicin. unique glucuronidation pathway for 4'-epidoxorubicin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of 4-demethoxydaunorubicin administered orally

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nogalamycin analogs having improved antitumor activity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

4'Epidoxorubicin (epirubicin): activity in hepatocellular carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of epirubicin in advanced malignant melanoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxic and therapeutic activity of 4'-epi-doxorubicin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of the anthracycline agent, 7-con-O-methylnogarol (7-OMEN), administered orally to mice bearing P388 or L1210 leukemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Menogaril: a new anthracycline agent entering clinical trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of Idarubicin (4-demethoxydaunorubicin) in adult acute leukemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human pharmacokinetics of esorubicin (4'-deoxydoxorubicin)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of glycoprotein biosynthesis by the inducers of HL-60 cell differentiation, aclacinomycin A and marcellomycin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of 4'-epi-doxorubicin in metastatic renal cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II clinical evaluation of 4'-epi-doxorubicin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intracellular uptake of 7-con-o-methylnogarol and adriamycin by cells in culture and its relationship to cell survival

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of epirubicin in gastric cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial with 4'-deoxydoxorubicin (esorubicin).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on the comparative distribution and biliary excretion of doxorubicin and 4'-epi-doxorubicin in mice and rats

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of epirubicin in advanced adenocarcinoma of the pancreas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2948729

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/BF00273384

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2948729

retrieved

12 September 2017

PubMed publication ID

2948729

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2948729

retrieved

12 September 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39480685&oldid=2202917955"